Studies related to Walking and Cannabis

Smoked Cannabis For Spasticity In Multiple Sclerosis: A Randomized, Placebo-controlled Trial

Effect Increase
Trial Design Randomized trial
Trial Length 1-7 Days
Number of Subjects 37
Sex Both Genders
Notes for this study:
In a randomized, double-blind, placebo-controlled crossover trial, 37 participants with multiple sclerosis to smoke a cannabis cigarette once daily for three days or a placebo cigarette, with a11 days of washout in between.

The primary outcome was the change in spasticity as measured by patient score on the modified Ash-worth scale. There was a statistically significant improvement in spasticity, pain, physical performance (via walking time), and cognitive function. Fatigue was perceived to be significantly decreased, while cognitive deficits and overall symptoms weren't statistically significantly lower.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.